Defective Drug SJS Cases in California: Get Justice

What Is Stevens-Johnson Syndrome (SJS)?

Stevens-Johnson syndrome is a severe immune-mediated reaction affecting the skin and mucous membranes. It is often, but not always, drug-induced, can progress rapidly, and may require hospitalization and intensive or burn-unit level care with long-term follow-up. Symptoms may include flu-like onset, painful rash, blistering, detachment of the top layer of skin, eye involvement, and complications affecting internal organs. Toxic epidermal necrolysis (TEN) is a more extensive condition on the same spectrum.

How Defective or Inadequately Labeled Drugs Can Be Involved

Many SJS cases have been reported in connection with medications. Under California products-liability law, a drug may be alleged to be defective due to inadequate warnings or instructions or a manufacturing defect, and in some contexts, design theories may be asserted for non-prescription products. Failure to reasonably warn about SJS risks, drug interactions, or early warning signs can render a product not reasonably safe under strict-liability failure-to-warn principles recognized by California courts.

California permits claims not only against the manufacturer but also others in the chain of distribution, depending on the facts.

Common Drug Categories Associated with SJS

SJS has been reported with several classes of medications, including antibiotics, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain gout and pain medications. Risk varies by drug and patient factors. Always discuss risks, benefits, and early symptoms that require urgent care with your prescribing clinician.

Potential Legal Claims in California

• Strict products liability for failure to warn or manufacturing defect. For prescription drugs, California generally does not allow strict-liability design-defect claims; most prescription drug cases focus on warnings and manufacturing defects.
• Negligence, such as negligent failure to warn, inadequate testing, or post-market surveillance issues.
• Breach of warranty in appropriate circumstances.
• Fraud or misrepresentation in limited, fact-specific situations.

California courts have articulated strict-liability failure-to-warn principles and apply risk-benefit and consumer-expectations frameworks in design-defect cases for many products. For prescription drugs, however, design-defect strict liability is generally barred under California law.

Causation and Warning Adequacy

In drug cases, medical expert testimony typically links the medication to SJS in the specific circumstances. Warning adequacy turns on whether the manufacturer provided reasonable instructions and risk disclosures in light of the state of scientific knowledge at the time. California follows the learned intermediary doctrine in prescription drug cases (warnings directed to prescribing clinicians) and recognizes that strict-liability failure-to-warn requires risks that were knowable at the time.

Federal Preemption and Brand/Generic Issues

Some claims, especially against generic drug manufacturers, may be limited by federal preemption. The U.S. Supreme Court has held that brand-name failure-to-warn claims are generally not preempted in the absence of clear evidence the FDA would have rejected the change, while many failure-to-warn and design-defect claims against generics have been found preempted. These doctrines are complex and fact-dependent; consult counsel about how they may affect your case.

Evidence That Strengthens an SJS Case

• Medical records confirming SJS or TEN diagnosis and course of treatment.
• Medication history, pharmacy records, and timing of symptom onset.
• Labeling or prescribing information and any Medication Guide in effect when you took the drug.
• Regulatory communications and adverse event data relevant to the product.
• Expert opinions on causation and adequacy of warnings.
• Damages documentation: hospitalizations, surgeries, vision impacts, scarring, lost income, and long-term care needs.

Dealing With Manufacturers and Insurers

Manufacturers and insurers may dispute causation, argue warnings were adequate, or blame other factors. Avoid recorded statements or broad authorizations before speaking with counsel. An attorney can preserve evidence, consult medical experts, and negotiate while preparing the case for litigation if needed.

Time Sensitivity and Filing Considerations

California imposes deadlines to bring product-liability and personal-injury claims. Many personal-injury claims must be filed within two years, subject to the discovery rule and other tolling doctrines. Different claims, such as warranty, may have different periods. Because deadlines turn on specific facts, speak with a California products-liability attorney as soon as possible to evaluate your timeline.

What Compensation May Be Available

Depending on the evidence, recoverable damages may include medical expenses (past and future), lost earnings and diminished earning capacity, pain and suffering, disfigurement and disability, and, in appropriate cases, punitive damages where the standard is met. Every case is fact-specific.

Key Legal Authorities (Links)

• Strict-liability failure to warn: Anderson v. Owens-Corning Fiberglas Corp., 53 Cal.3d 987 (1991)
• Design-defect frameworks (general products): Barker v. Lull Engineering Co., 20 Cal.3d 413 (1978)
• Prescription drugs, design-defect strict liability generally barred: Brown v. Superior Court, 44 Cal.3d 1049 (1988); warnings and learned intermediary: Carlin v. Superior Court, 13 Cal.4th 1104 (1996)
• Chain of distribution liability: Vandermark v. Ford Motor Co., 61 Cal.2d 256 (1964)
• Negligence principles: Cal. Civ. Code § 1714
• Statute of limitations (personal injury): Cal. Code Civ. Proc. § 335.1; discovery rule example: Jolly v. Eli Lilly & Co., 44 Cal.3d 1103 (1988)
• Punitive damages standard: Cal. Civ. Code § 3294
• Federal preemption: Wyeth v. Levine, 555 U.S. 555 (2009); PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011); Mutual Pharm. Co. v. Bartlett, 570 U.S. 472 (2013)

FAQ

What is the difference between SJS and TEN?

They are on the same spectrum; TEN involves a larger body surface area of skin detachment than SJS.

Can I sue if I took a generic drug?

Some claims against generic manufacturers may be preempted by federal law, but other avenues may exist depending on the facts. Speak with a California attorney about your options.

Do I need an expert for my case?

Yes. Medical expert testimony is typically needed to prove causation and evaluate warning adequacy.

How long do I have to file in California?

Many personal injury claims have a two-year deadline, subject to the discovery rule and other exceptions. Do not wait to get advice specific to your case.

How a California SJS Lawyer Can Help

An attorney can investigate the drug’s safety profile and regulatory history, identify responsible parties, coordinate expert reviews, calculate damages, and file and prosecute your claims. Early involvement improves evidence preservation and positioning for settlement or trial.

Next Steps

If you or a loved one suffered SJS after taking a medication, our California products-liability team can help. Contact us for a free, confidential evaluation.